Search
for

    Sort by

    Research 121–150 of 1000+

    1. FINASTERIDE AND PSA The Journal of Urology · 2005
    2. 5α-reductase inhibitors/finasteride The Prostate · 1996 · 24 citations
    3. Absence of Prostatic Growth in Large Cohort of Adult Female Patients with Congenital Adrenal Hyperplasia The Journal of Urology · 2012 · 7 citations
    4. PSA Test Sensitized by Finasteride Oncology times · 2006 · 1 citations
    5. 1747 PREDICTION OF BLADDER PROSTATIC OBSTRUCTION: DEVELOPMENT OF A SIMPLIFIED CLINICAL NOMOGRAM The Journal of Urology · 2013
    6. Επικύρωση της χρησιμότητας των νεότερων παραμέτρων του PSA ορού για την ανίχνευση του καρκίνου του προστάτη 2018
    7. Long-Term Experience With 5-alpha-Reductase Inhibitors. PubMed · 2003 · 6 citations
    8. Dutasteride: a review of current data on a novel dual inhibitor of 5alpha reductase. PubMed · 2005 · 38 citations
    9. Mitoxantrone Drugs & Aging · 1997 · 60 citations
    10. Comparison of Clinical Efficacy of Finasteride and Dutasteride as 5-alpha Reductase Inhibitor Daehan namseong gwahag hoeji · 2012 · 1 citations
    11. Side effects of androgen deprivation therapy: monitoring and minimizing toxicity Urology · 2003 · 228 citations
    12. [Combined treatment of BPS with tamsulosin and finasteride : Literature review and prescription data]. Urologe A · 2017 · 1 citations
    13. Screening: seeking a balance Lancet Oncology · 2006
    14. Male Pattern Baldness in Relation to Prostate Cancer–Specific Mortality: A Prospective Analysis in the NHANES I Epidemiologic Follow-up Study American Journal of Epidemiology · 2016 · 17 citations
    15. Case-Only Trees and Random Forests for Exploring Genotype-Specific Treatment Effects in Randomized Clinical Trials with Dichotomous End Points 2019 · 5 citations
    16. Pharmacology of antiandrogens Journal of Steroid Biochemistry · 1986 · 97 citations
    17. SARS-CoV-2 vaccination in androgen sensitive phenotypes – A study on associated factors for SARS-CoV-2 vaccination and its adverse effects among androgenetic alopecia and benign prostate hyperplasia patients Frontiers in Immunology · 2022
    18. Protective role of agomelatine via modulation of TLR4/NF-κB: NLRP3/IL-1β signaling pathways in testosterone-induced benign prostatic hyperplasia in rats Naunyn-Schmiedeberg s Archives of Pharmacology · 2025
    19. Hair, Hormones, and High-Risk Prostate Cancer Journal of Clinical Oncology · 2014 · 3 citations
    20. 9 Role of 5α-reductase in health and disease Baillière's clinical endocrinology and metabolism · 1994 · 101 citations
    21. Male pattern baldness and the risk of prostate cancer Annals of Oncology · 2011 · 38 citations
    22. Hétérogénéité tumorale du cancer de la prostate et infection par le SARS-CoV2 : une relation complexe impliquant les vésicules extracellulaires et le récepteur des androgènes SPIRE - Sciences Po Institutional REpository · 2023
    23. The Risks and Benefits of 5α-Reductase Inhibitors for Prostate-Cancer Prevention 2011 · 147 citations
    24. Sex differences in SARS-CoV-2 infection rates and the potential link to prostate cancer Communications biology · 2020 · 113 citations
    25. Efficacy and Side Effects of Drugs Commonly Used for the Treatment of Lower Urinary Tract Symptoms Associated With Benign Prostatic Hyperplasia Frontiers in Pharmacology · 2020 · 35 citations
    26. RE: EFFECT OF THE DUAL 5α-REDUCTASE INHIBITOR DUTASTERIDE ON MARKERS OF TUMOR REGRESSION IN PROSTATE CANCER 2005 · 3 citations
    27. Epitestosterone 2003 · 59 citations
    28. Prostate Cancer Early Detection, Version 2.2015 Journal of the National Comprehensive Cancer Network · 2015 · 67 citations
    29. T-Cell Reconstitution after Thymus Xenotransplantation Induces Hair Depigmentation and Loss 2013 · 7 citations
    30. Factors associated with early-onset androgenetic alopecia: A scoping review PLOS ONE · 2024